Advanced search
Publication Cover
ClinicoEconomics and Outcomes Research Volume 11, 2019 - Issue
Submit an article Journal homepage
161
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Cost-consequence analysis for human recombinant growth hormone (r-hGH) treatment administered via different devices in children with growth hormone deficiency in Italy

Jason Foo1 Global Health Economics, Mapi Group (An ICON plc Company), Houten, The NetherlandsCorrespondence[email protected]
,
Mohamad Maghnie2 Department of Pediatrics, IRCCS Istituto Giannina Gaslini Institute, University of Genova, Genova, Italy
,
Annamaria Colao3 Department of Clinical Medicine and Surgery, University Federico II of Naples, 80131Napoli, Italy
,
Ioanna Vlachaki4 Global Health Economics, ICON plc, London, UK
&
Giorgio Colombo5 Department of Drug Science, Pavia University, Pavia, Italy;6 SAVE Studi – Health Economics & Outcomes Research, Milan, ItalyORCID Iconhttps://orcid.org/0000-0002-5790-8891
ORCID Icon
Pages 525-537 | Published online: 22 Aug 2019

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Simone Rivolo, Jane Loftus, Balazs Peter, Marion Fahey & Thitima Kongnakorn. (2023) Cost-effectiveness and cost-utility analysis of somatrogon once-weekly injections vs. daily growth hormone injection for treating paediatric growth hormone deficiency in Ireland. Journal of Medical Economics 26:1, pages 963-972.
Read now
Manabu Akazawa, Daisuke Shima, Takahiro Sato, Emi Shoji, Michael LoPresti & Ryosuke Nishi. (2022) Perception of Adherence to Daily Human Growth Hormone Treatments Among Pediatric and Adolescent Patients in Japan: A Cross-Sectional Survey of Physicians and Caregivers. Patient Preference and Adherence 16, pages 3081-3094.
Read now

Articles from other publishers (5)

Vincenzo Tornincasa, David Dixon, Quentin Le Masne, Blaine Martin, Lilian Arnaud, Paula van Dommelen & Ekaterina Koledova. (2022) Integrated Digital Health Solutions in the Management of Growth Disorders in Pediatric Patients Receiving Growth Hormone Therapy: A Retrospective Analysis. Frontiers in Endocrinology 13.
Crossref
Massimiliano Orso, Barbara Polistena, Simona Granato, Giuseppe Novelli, Roberto Di Virgilio, Daria La Torre, Daniela d’Angela & Federico Spandonaro. (2022) Pediatric growth hormone treatment in Italy: A systematic review of epidemiology, quality of life, treatment adherence, and economic impact. PLOS ONE 17:2, pages e0264403.
Crossref
Aria Reza Assefi, Fernanda Roca, Adrián Rubstein & Cinthia Chareca. (2021) Positive Impact of Targeted Educational Intervention in Children With Low Adherence to Growth Hormone Treatment Identified by Use of the Easypod™ Electronic Auto-injector Device. Frontiers in Medical Technology 3.
Crossref
Marco Cappa, Mohamad Maghnie, Vincenza Carbone, Laura Chioma, Carmela Errichiello, Claudia Giavoli, Mario Giordano, Laura Guazzarotti, Antonella Klain, Giovanni Montini, Luisa Murer, Maria Parpagnoli, Carmine Pecoraro, Sabino Pesce & Enrico Verrina. (2020) Summary of Expert Opinion on the Management of Children With Chronic Kidney Disease and Growth Failure With Human Growth Hormone. Frontiers in Endocrinology 11.
Crossref
. (2019) Somatropin easypod good value in growth-hormone deficiency. PharmacoEconomics & Outcomes News 836:1, pages 26-26.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.